Skip to main content
Equibles

NewEdge Wealth, LLC

Position in CRL — Charles River Laboratories International, Inc.

CIK 1861796 STAMFORD, CT
Back to CRL Full portfolio

Position in CRL

as of Jun 30, 2026 · filed Aug 10, 2026
Position Value
$247,427
-$267,231 QoQ
Shares Held
1,091
-57.7% QoQ
Ownership
0.002%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#385
of 571 holders
Holding Since
Dec 2020
20 quarters on record
Voting authority Sole 0% Shared 0% None 100%

Common Shares in CRL Over Time

Shares Held

Position Value (USD)

Position in Diagnostics & Research

Healthcare · as of Jun 30, 2026

NewEdge Wealth, LLC holds $44,743,682 across 11 Diagnostics & Research names. CRL ranks #8 (0.6% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 MEDP
Medpace Holdings, Inc.
 51,943 $27,508,493
2 TMO
Thermo Fisher Scientific Inc.
 10,697 $5,363,047
3 DHR
Danaher Corp /De/
 23,171 $4,413,612
4 IDXX
Idexx Laboratories Inc /De
 5,843 $3,075,988
5 ICLR
Icon PLC
 8,345 $1,449,609
6 NTRA
Natera, Inc.
 4,928 $1,337,705
7 A
Agilent Technologies, Inc.
 5,030 $668,134
8 CRL
Charles River Laboratories International, Inc.
This page 		1,091 $247,427

All Filings in CRL

Export CSV
20 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $247,427 1,091
2025-12-31 $514,658 2,580
2025-03-31 $3,215,709 21,364
2024-12-31 $3,131,000 16,961
2024-09-30 $4,233,279 21,492
2024-06-30 $4,205,349 20,357
2024-03-31 $5,452,326 20,123
2023-12-31 $4,301,534 18,196
2023-09-30 $3,311,082 16,895
2023-06-30 $3,231,752 15,371
2023-03-31 $2,978,055 14,756
2022-12-31 $3,088,078 14,172
2022-09-30 $2,779,209 14,122
2022-06-30 $2,824,617 13,201
2022-03-31 $2,251,314 7,928
2021-12-31 $2,475,821 6,571
2021-09-30 $2,640,262 6,398
2021-06-30 $2,040,848 5,517
2021-03-31 $1,545,953 5,334
2020-12-31 $220,876 884